Nomura's Top Picks: Hindustan Unilever, Lupin, and Anant Raj for Up to 21% Upside Potential
PorAinvest
martes, 30 de septiembre de 2025, 4:47 am ET1 min de lectura
UL--
Hindustan Unilever, a consumer goods giant, has been given a 'Buy' rating with a target price of Rs 2,900, translating to an estimated 15% upside. Nomura attributes this recommendation to the company's expected normalized standalone/consolidated sales growth of 3%/4% YoY, despite the temporary impact of GST announcements in September [1]. The brokerage expects a recovery in demand from November as prices stabilize.
Lupin, a pharmaceutical company, has also been rated 'Buy' by Nomura with a target price of Rs 2,350, indicating an upside of approximately 21%. The brokerage highlights Lupin's strategic acquisition of VISUfarma, a specialty ophthalmology company in Europe, as a significant growth driver. This move is expected to boost Lupin's presence in a branded and relatively stable segment, with the European ophthalmology market growing at around 5% annually and VISUfarma expected to grow at 7% CAGR over the next three years [1].
Anant Raj, a data center company, is the third pick with a target price of Rs 700, suggesting a 3% upside. Nomura sees potential in the data center segment, noting the company's early start and relatively lower capex costs. The brokerage expects Anant Raj to lease 24 MW of capacity for colocation and 1–2 MW for cloud clients, with targeted FY26 revenue from the segment around Rs 150–200 crore [1].
These recommendations reflect Nomura's optimism about the growth prospects of these companies in their respective sectors. Investors should carefully consider these recommendations along with their own financial goals and risk tolerance.
Nomura recommends three "Buy" stocks: Hindustan Unilever, Lupin, and Anant Raj. Hindustan Unilever has a target price of Rs 2,900, with a 15% upside potential, while Lupin's target price is Rs 2,350, with a 21% upside potential. Anant Raj's target price is Rs 700, with a 3% upside potential. The brokerage firm expects strong returns from these stocks due to their potential growth in their respective sectors.
In a recent report, Nomura has recommended three stocks—Hindustan Unilever, Lupin, and Anant Raj—for investors looking to capitalize on potential growth opportunities. The brokerage firm expects these stocks to deliver strong returns, with upside potential ranging from 3% to 21%.Hindustan Unilever, a consumer goods giant, has been given a 'Buy' rating with a target price of Rs 2,900, translating to an estimated 15% upside. Nomura attributes this recommendation to the company's expected normalized standalone/consolidated sales growth of 3%/4% YoY, despite the temporary impact of GST announcements in September [1]. The brokerage expects a recovery in demand from November as prices stabilize.
Lupin, a pharmaceutical company, has also been rated 'Buy' by Nomura with a target price of Rs 2,350, indicating an upside of approximately 21%. The brokerage highlights Lupin's strategic acquisition of VISUfarma, a specialty ophthalmology company in Europe, as a significant growth driver. This move is expected to boost Lupin's presence in a branded and relatively stable segment, with the European ophthalmology market growing at around 5% annually and VISUfarma expected to grow at 7% CAGR over the next three years [1].
Anant Raj, a data center company, is the third pick with a target price of Rs 700, suggesting a 3% upside. Nomura sees potential in the data center segment, noting the company's early start and relatively lower capex costs. The brokerage expects Anant Raj to lease 24 MW of capacity for colocation and 1–2 MW for cloud clients, with targeted FY26 revenue from the segment around Rs 150–200 crore [1].
These recommendations reflect Nomura's optimism about the growth prospects of these companies in their respective sectors. Investors should carefully consider these recommendations along with their own financial goals and risk tolerance.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios